SB 12 — Kentucky
AN ACT relating to prescription drugs.
History
- Introduced, completed
- Passed Senate, in progress
- Passed House, not reached yet
- Sent to Governor, not reached yet
- Signed into law, not reached yet
Kentucky legislative agenda & upcoming votes Kentucky session calendar
Summary
Amend KRS 304.17A-164 to define terms; establish cost-sharing requirements for prescription drugs; require rebates to be passed through; establish confidentiality requirements for the rebate information; create a new section of KRS 365.880 to 365.900 to provide that the actual amount of rebates received is a trade secret; provide that compliance with prescription drug cost-sharing and rebate requirements shall not be in violation of the Uniform Trade Secrets Act; amend KRS 304.17C-125, 304.38A-115, 18A.225, and 164.2871 to apply the cost-sharing and rebate requirements for prescription drugs to limited health service benefit plans, limited health service organizations, the state employee health plan, and self-insured employer group health plans provided by the governing board of a state postsecondary education institution; apply provisions to health plans issued or renewed on or after January 1, 2026; EFFECTIVE January 1, 2026.
- SB 12 is a bill in the Kentucky Senate, 2025RS session, introduced January 7, 2025.
- Sponsored by S. Meredith, C. Richardson, and R. Thomas.
- Current status: introduced.
- Most recent action (January 9, 2025): to Banking & Insurance (S).
- Subjects: Actuarial Analysis, Drugs and Medicines, Education, Higher, Effective Dates, Delayed, Health Benefit Plan Mandate, Insurance, Health.
Sponsors
Primary sponsors (3)
Contact your legislator about this bill
Bill text & documents
Bill timeline
- Senate introduced in Senate Milestone
- Senate to Committee on Committees (S)
- Senate to Banking & Insurance (S) Latest